GLP-1 fatigue: why the tiredness hits and what is actually behind it
Tiredness on a GLP-1 medicine is common enough to be printed on the label, and it almost always has a cause you can name. Usually it is fluid, food, or where you sit in the dose cycle. Sometimes it is none of those.

Fatigue is a labeled side effect of GLP-1 medicines: 11% of adults on semaglutide 2.4 mg reported it against 5% on placebo. The usual explanations are dehydration, a sharp drop in what you are eating, and the days right after a shot, when the level in your body is highest.
What the research shows
Fatigue is not a forum rumor. It sits in the adverse reactions tables of the FDA labels.
In the Wegovy label, 11% of adults on semaglutide 2.4 mg reported fatigue against 5% on placebo. In the Zepbound label it climbs with dose: 5% at 5 mg, 6% at 10 mg, 7% at 15 mg, against 3% on placebo. Zepbound also spells out that its fatigue category covers asthenia, lethargy and malaise.
So it happens more on the medicine than off it. Most people in those trials never reported it, so it is not the price of admission either.
The labels never claim the drug switches your energy off. What they document are the routes. Both tie reported acute kidney injury to gastrointestinal side effects and dehydration, and both tell prescribers to watch kidney function when a reaction could cause volume depletion.
The other route is food. In a 20 week randomized trial, adults with obesity on semaglutide 2.4 mg ate 35% less at a laboratory lunch than adults on placebo, 1736 kJ against 2676 kJ.
Why it happens and when to expect it
Four explanations cover most of it, and they stack.
The first is fluid. Nausea makes you drink less, vomiting or loose stools take more out, and much of your daily water normally arrives inside food you are no longer eating. Dehydration can read as heaviness and no drive long before it reads as thirst.
The second is intake. Very low intake, held for weeks, is a plain cause of low energy.
The third is the phase of the cycle, and nobody mentions it. A weekly injection does not deliver a flat week. Semaglutide reaches its maximum concentration 1 to 3 days after the dose, tirzepatide 8 to 72 hours after it. The peak is early, and so are the side effects that feed the tiredness.
A second clock runs underneath. Semaglutide has a half-life of about 7 days and reaches steady state after 4 to 5 weeks, tirzepatide about 5 days and roughly 4 weeks. Doses every 7 days do not clear before the next one lands, so the level climbs through the first month after a start or a step up. Week six is not week two.
The fourth is blood sugar, and it applies to a narrower group. Both labels warn that taking one of these medicines alongside insulin or a sulfonylurea raises the risk of low blood sugar. In the Zepbound trial of adults who also had type 2 diabetes, low blood sugar was reported in 10.3% of those taking a sulfonylurea as well, against 2.1% of those on Zepbound without one. Low blood sugar can feel like weakness and a sudden drop in energy, and that combination is a question for your prescriber.
What actually helps
None of this involves touching your dose. It sits in the space between doses, the part you control.
Drink to a schedule instead of to thirst. Put water where you already are and treat it as a task, not an urge, especially in the days right after your shot.
Eat at set times even when nothing appeals. Waiting for hunger the medicine has removed turns into a fourteen hour gap you never decided on. And check what else changed: a new medicine, bad sleep, a cold, a hard month.
The one that matters most: write it down with the date. Three weeks of tiredness, logged against the day of your cycle, either shows a pattern or shows there is none. The second answer is what your prescriber needs in order to look elsewhere.
- Water on a schedule, not on thirst, especially after a dose
- Something to eat at regular times even without appetite
- A note of anything else that changed: sleep, illness, other medicines
- The symptom logged with a date and an intensity
- Any question about the dose taken to your prescriber, never solved at home
When to call your prescriber
Ordinary tiredness that fades as the week goes on is different from the signs below, which the FDA label and MedlinePlus flag for a call rather than a wait.
Call about the fatigue itself when it does not follow your cycle, keeps deepening, or arrives with breathlessness or a racing heart. Anemia, thyroid problems and sleep apnea cause tiredness too, and someone has to go looking.
Call too if you cannot keep liquids down, the fastest route from a rough few days to real dehydration. If you take insulin or a sulfonylurea, treat dizziness, sweating or sudden weakness as possible low blood sugar and follow the plan your prescriber gave you.
And get medical help right away for any of these.
- Ongoing pain in the upper left or middle of your stomach, which may spread to your back
- Decreased urination, or swelling of the legs, ankles or feet
- Yellowing of the skin or eyes, fever, or clay colored stools
- Rash, itching, fainting, swelling of the face or throat, or trouble breathing or swallowing
- Vision changes, or a rapid or pounding heartbeat
How Setva helps you see it coming
The hard part is not the biology. It is that a bad Tuesday in July and a bad Tuesday in August never sit next to each other in your head.
Setva is an iPhone app for GLP-1 treatment. You log your shot or daily tablet in two taps, tag fatigue with one tap and an intensity, and the app files it against the day of your dose cycle rather than the day of the week. After a few weeks the scattered bad days turn into a shape: heavy on day 2, clear by day 5, or nothing consistent at all.
Above it sits the curve, an estimate of how much medicine is still in your body, built from your logged doses and the published half-life for your product. It is an educational estimate, not a measurement of your blood, and it never suggests a change to your dose. It shows the ramp of the first weeks and the peak after each shot, so a hard day gets a place on a line.
Your dose history, symptoms and weight stay on your iPhone and in your own private iCloud. No account, no login, no server of ours. Setva is not on the App Store yet, so the waitlist is how you hear about launch day, at 79.99 USD a year or 12.99 USD a week with no trial.
Setva is coming to the App Store. Join the waitlist and you will hear from us once, the day it goes live.
The bottom line
Fatigue on a GLP-1 medicine is real, it is on the label, and it is usually not mysterious. Fluid, food and the phase of the cycle explain most of it, and all three peak in the same window: a new dose, and the days right after each shot.
Drink on purpose, eat on a schedule, and write down what you feel with the date attached. If the tiredness has a shape, three weeks of notes will show it.
Questions people ask
How common is fatigue on a GLP-1 medicine?
In the Wegovy label, 11% of adults on semaglutide 2.4 mg reported it against 5% on placebo. In the Zepbound label it ran from 5% to 7% by dose, against 3% on placebo.
Which day is the tiredness worst?
For most people it clusters in the days right after the shot, when the level is highest. Semaglutide peaks 1 to 3 days after a dose, tirzepatide 8 to 72 hours after one.
Does the fatigue go away?
It often eases as your body settles at a dose, and it can return after an increase. Steady state takes 4 to 5 weeks for semaglutide and about 4 weeks for tirzepatide, so the first month of anything new is the loudest.
Could it just be dehydration?
Often, yes. Nausea cuts what you drink, vomiting and loose stools take more out, and much of your daily water normally arrives inside food you are no longer eating.
Should I change my dose because of the fatigue?
That is not a decision to make at home, and no app should offer an opinion on it. Bring your logged symptoms and their dates to your prescriber. Never skip, split or double a dose on your own.
When does tiredness mean something other than the medicine?
When it does not follow your dose cycle, keeps deepening, or comes with breathlessness, decreased urination or swelling in your legs. Anemia, thyroid problems and sleep apnea need a person to look for them.
Sources
- FDA prescribing information, Wegovy (semaglutide) injection and tablets
- FDA prescribing information, Zepbound (tirzepatide) injection
- FDA prescribing information, Ozempic (semaglutide) injection, clinical pharmacology
- FDA prescribing information, Mounjaro (tirzepatide) injection, clinical pharmacology
- Friedrichsen M et al. The effect of semaglutide 2.4 mg once weekly on energy intake, appetite, control of eating, and gastric emptying in adults with obesity. Diabetes Obes Metab, 2021
- MedlinePlus, Semaglutide Injection
This is an educational estimate based on published half-life data, not a measurement of your blood. Never change your dose without your prescriber.